Streamline Health Solutions (NASDAQ:STRM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Tuesday morning. The brokerage issued a sell rating on the stock.

Streamline Health Solutions Stock Performance

NASDAQ STRM opened at $2.50 on Tuesday. The firm has a market cap of $10.68 million, a P/E ratio of -1.04 and a beta of 1.78. The company has a quick ratio of 0.46, a current ratio of 0.46 and a debt-to-equity ratio of 0.72. The company’s 50 day moving average is $2.70 and its 200-day moving average is $3.14. Streamline Health Solutions has a 12-month low of $1.82 and a 12-month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.10). The firm had revenue of $4.70 million during the quarter, compared to analysts’ expectations of $4.70 million. Streamline Health Solutions had a negative return on equity of 56.96% and a negative net margin of 50.51%.

Institutional Investors Weigh In On Streamline Health Solutions

A hedge fund recently raised its stake in Streamline Health Solutions stock. Nicholas Hoffman & Company LLC. grew its holdings in Streamline Health Solutions, Inc. (NASDAQ:STRM) by 8.7% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 52,299 shares of the company’s stock after buying an additional 4,166 shares during the quarter. Nicholas Hoffman & Company LLC. owned approximately 1.22% of Streamline Health Solutions worth $146,000 at the end of the most recent quarter. Institutional investors and hedge funds own 31.74% of the company’s stock.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.